Eye drop trial aims to delay cornea transplants for common vision disease
NCT ID NCT04440280
Summary
This study is testing whether N-acetyl cysteine (NAC) eye drops can slow the progression of Fuchs' endothelial corneal dystrophy, a common eye disease that currently requires corneal transplant surgery. About 45 adults with advanced Fuchs' and cataracts will use either NAC drops or placebo drops for 28 days before their scheduled combined cataract and corneal transplant surgery. Researchers will measure oxidative stress in eye fluid and check if the drops improve vision symptoms or corneal health to see if this treatment could become a new option to manage the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS ENDOTHELIAL CORNEAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts Eye and Ear Infirmary
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.